Stan Wong Reveals His Top Stock Choices for July 2024

Top Stocks for July 2024: Insights from Stan Wong, Portfolio Manager at Scotia Wealth Management

Editorial Team (ET)July 3, 2025

Stan Wong, a portfolio manager at Scotia Wealth Management, is renowned for his expertise in North American large caps and ETFs. As we delve into his top picks for July 11, 2024, we’ll explore the market outlook and analyze the potential of his selected stocks: Lennox International, Netflix, and Novo Nordisk. This article provides an in-depth look at the current market environment and why these companies stand out in Stan Wong’s portfolio.

Market Outlook

Global equities have shown impressive stamina in 2024, with the U.S. mega-cap growth stocks leading the charge. The S&P 500 Index has surged over 18% year-to-date, while the tech-heavy Nasdaq Composite Index has soared more than 24%. In contrast, the Dow Jones Industrial Average and the S&P/TSX Composite Index have delivered more modest growth, both rising just over 5% year-to-date. This divergence highlights the dominance of the technology sector in driving market performance.

The U.S. technology sector has continued its leadership from 2023 into 2024, driven by strong growth in cloud computing, artificial intelligence (AI), and cybersecurity. However, high valuations in this sector pose significant risks, as the S&P 500 Information Technology Index trades near 20-year highs. On the other hand, the real estate and materials sectors have lagged, reflecting broader market dynamics and investor sentiment.

In such a complex landscape, diversification remains crucial. Investors must balance opportunities and risks, maintaining a well-diversified portfolio aligned with proper risk and return objectives. A comprehensive financial plan can help navigate market oscillations effectively, ensuring long-term growth and stability.

Economic Perspective

The world economy is projected to grow by 3% in both 2024 and 2025. While advanced economies show slight acceleration, emerging markets face potential slowdowns. This uneven growth requires strategic allocation to maximize returns while managing risks.

Recent interest rate cuts by the Bank of Canada and the European Central Bank mark a significant shift in monetary policy. In the U.S., strong consumer spending and moderating inflation raise hopes for potential interest rate cuts later this year. Meanwhile, Canada’s economy is expected to slow for the remainder of 2024, with retail sales moderating, manufacturing softening, and home sales shrinking. The unemployment rate in Canada has also increased to 6.4%.

Stan Wong’s Investment Philosophy

Stan Wong maintains a constructively optimistic outlook for equity markets. Decelerating inflation and falling interest rates, coupled with a record level of U.S. money market assets, should keep market sentiment positive. Identifying high-quality, secular growth companies remains a core focus in his portfolio mandates.

Wong favors sectors such as health care, consumer discretionary, financials, and technology, provided valuations are reasonable. His geographic allocation includes approximately 60% U.S. equities, 25% Canadian equities, and 15% international equities. Within fixed income, he prefers government and investment-grade corporate bonds with both short and medium durations. This strategic allocation aims to enhance returns while prudently managing risk.

Top Picks for July 2024

Lennox International (LII NYSE)

Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration (HVACR) products to replacement and new construction markets. With replacement sales representing 75% of overall sales and new construction 25%, Lennox has a balanced revenue stream. Over 90% of its revenue is generated from the U.S., with a strong focus on residential HVAC units.

Lennox enjoys strong brand recognition and an extensive distribution network, allowing it to maintain a competitive advantage and growing market share. The company is well-positioned to benefit from trends such as elevated demand for energy-efficient and environmentally friendly HVAC systems, aging infrastructure, increasing urbanization, and rising global temperatures.

Lennox shares have been trending upwards since mid-2022, with a clear channel of higher highs and higher lows. The company is forecasted to achieve an average annual earnings growth rate of more than 15% over the next several years. Lennox reports its next quarterly results on July 24.

Netflix (NFLX NASD)

With over 260 million global subscribers and nearly $39 billion in projected fiscal 2024 revenue, Netflix continues to dominate the subscription streaming service industry. The company’s focus on original content production has allowed it to differentiate its service and build a global customer base.

Netflix is expanding its footprint into emerging markets, tapping into significant subscriber growth potential. The introduction of advertising-supported subscriptions offers an additional revenue stream, attracting cost-conscious consumers and advertisers seeking premium inventory.

Netflix shares have been outpacing the broader S&P 500 Index since early 2022, with a clear uptrend channel of higher highs and higher lows. The company is forecasted to achieve an annual earnings growth rate of over 35% in the coming years. Netflix reports its next quarterly results on July 18.

Novo Nordisk A/S ADR (NVO NYSE)

Headquartered in Denmark, Novo Nordisk is a leading global healthcare company and Europe’s most valuable listed company, with a market capitalization of over $635 billion. The company holds a dominant position in the rapidly growing diabetes and obesity treatment markets.

Novo Nordisk supplies half of the world’s insulin and commands one-third of the diabetes treatment market. With over 40 million people worldwide benefiting from its drugs, the company is experiencing unprecedented growth driven by continued consumer demand for blockbuster medications like Ozempic and Wegovy.

Novo Nordisk shares have been outpacing the broader market indices since early 2017, maintaining a strong upward trend. The company is poised to deliver an annual earnings per share growth rate of over 25% in the coming years. Novo Nordisk reports its next quarterly results on August 7.

Conclusion

Stan Wong’s market insights and top picks for July 2024 underscore the importance of strategic diversification and a focus on high-quality growth companies. Lennox International, Netflix, and Novo Nordisk each offer unique opportunities for investors seeking robust returns in a dynamic market environment.

Bloomberg

Disclaimer

This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.